U.S. Markets close in 5 hrs 43 mins

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
73.39-0.37 (-0.49%)
As of 10:17AM EDT. Market open.
People also watch
Full screen
Previous Close73.76
Bid73.45 x 300
Ask73.47 x 300
Day's Range73.30 - 73.99
52 Week Range63.76 - 88.85
Avg. Volume8,651,084
Market Cap95.91B
PE Ratio (TTM)7.76
Earnings DateN/A
Dividend & Yield2.08 (2.82%)
Ex-Dividend Date2017-06-14
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch3 hours ago

    Gilead Sciences says late-stage results for HIV drug combination are similar to standard of care

    Gilead Sciences Inc. said early Monday that its HIV combination treatment had similar safety and efficacy results in two late-stage clinical trials to the standard of care. The data, along with two other ...

  • Reuters6 hours ago

    HIV fight advances with new drug cocktails, fresh vaccine hopes

    Three decades after approval of the first-ever AIDS treatment, HIV medicine is seeing a new wave of innovation with scientists reporting positive data on Monday for improved drug cocktails and a novel experimental vaccine. The Achilles heel for us is drug resistance because the virus is incredibly quick to mutate," Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre in South Africa, said. The race for better and more convenient medicines has made HIV a rich battleground for drug companies such as Gilead Sciences and GlaxoSmithKline, which generate billions of dollars from modern therapies.

  • TheStreet.com20 hours ago

    The Worm Has Turned in Biotech's Favor

    But this needs to heat up again for the sector to rally in a big way.